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ABSTRACT 
 
Aims: Staphylococcus species have been a major human pathogen of public health importance 
globally. This study was designed to evaluate the resistance pattern and plasmid profile of 
Staphylococcus species isolated from clinical and community settings.  
Methodology: Staphylococcus species from clinical (55) and community (53) which were 
previously isolated in University of Ibadan and her teaching hospital and identified as                       
S. epidermidis (92.6%), S. aureus (6.5%) and S. xylosus (0.9%) were used. The antibiogram and 
plasmid profiles were determined by standard procedures.  
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Results: In clinical isolates of S. epidermidis, 30.9, 34.5, 40.0, 41.8, 60.0, 76.4, and 89.1% were 
resistant to chloramphenicol (CHL), streptomycin (STR), erythromycin (ERY), gentamycin (GEN), 
tetracycline (TET), cotrimoxazole (COT), and cloxacillin (CXC) respectively. Correspondingly, in 
community isolates of S. epidermidis, 28.3, 32.1, 50.9, 26.4, 58.5, 90.6 and 92.5% were resistant 
to these antibiotics. The only clinical S. xylosus isolated was resistant to all the antibiotics except 
CHL and STR. In the clinical isolates of S. aureus, 5.5, 5.5, 7.3, 7.3, 7.3, 9.1 and 9.1% were 
resistant to ERY, CHL, STR, GEN, TET, COT and CXC respectively. In community isolates, only 
one S. aureus was resistant to COT, CHL, ERY, GEN and STR while two were resistant to CXC.   
Plasmid profiling showed that 33/35 (94.3%) of clinical and 17/19 (89.5%) of community isolates 
had plasmid of size 23.13 kb.  
Conclusion: The increasing resistance and similarity of plasmid profile of the community isolates 
to clinical isolates call for urgent establishment of antibiotic surveillance system to minimize the 
emergence of drug resistance pathogens in the community. 
 
 
Keywords: Staphylococcus species; plasmid profile; resistance pattern.  
 
1. INTRODUCTION 
 
Staphylococcus species are Gram-positive, 
non-motile, non-sporing cocci occurring singly, 
in pair, and irregular clusters; colonies are 
opaque and may be white or creamy and are 
sometimes yellow or orange [1]. The genus 
Staphylococcus is pathogen of man and animals 
and colonizes the skin and mucosa membranes 
of their hosts [2]. Normally, they are grouped 
into two based their ability to clot blood plasma: 
coagulase positive staphylococci and coagulase 
negative staphylococci (CNS). Staphylococcus 
species have historically been a major human 
pathogen and continue to be one of the most 
commonly implicated bacteria causing human 
diseases throughout the world [3]. Its infection 
has become a global problem in both health 
institutions and community setting especially     
with the emergence of multi-drug resistant 
Staphylococcus aureus, MRSA [4]. 
 
Drug resistance has been an issue in the         
fight against bacterial infections. When new 
antibiotic is introduced into clinical practice, 
bacteria have been observed to resist such new 
drug after some months or years of continuous 
use [5-6]. The time of emergence and the               
rate of spread of resistant organisms can             
be unpredictable. Bacterial resistance occurs 
whenever the pathogens continue to reproduce 
at therapeutically attainable concentrations of 
the antibacterial agents. Resistance could occur 
extremely slow as observed with the resistance 
of Staphylococcus to neomycin, which was 
discovered only after nine years of clinical 
application [7]. Bacteria acquire resistance to 
antibiotics and other antibacterial agents either 
through chromosomal or extra chromosomal 
mediation [8]. Bacterial resistance of 
chromosomal origin was noticed shortly after 
the first antibiotics were put into large           
scale use, with the attendant indiscriminate 
administration of antibiotics and antibacterial 
agent [9]. 
 
The problem of bacterial resistance has been 
compounded with the discovery of various drug-
inactivating enzymes in most bacteria. Notable   
among these enzymes are ß-lactamases,                 
which act on susceptible antibiotics with cell   
wall acting activity and the transferases                    
(O-phosphotransferases, O-adenyltransferases 
and N-acetyltransferases) with activity on 
certain aminoglycosides [10-11]. Most of these 
enzymes are coded by plasmid and plasmid 
mediated drug resistance in Staphylococcus 
aureus was reported specifically with 
gentamycin, tobramycin, kanamycin and 
chloramphenicol [12]. This discovery therefore, 
necessitated a shift of emphasis from a 
restrictive form of resistance mediated by            
extra chromosomal determinant. The eventual 
appearance of strains of staphylococci with 
multiple antibiotics significantly worsened this 
problem. This was found to involve different 
resistance genes linked to each other on 
segments of DNA capable moving from one 
bacterial cell to another by phenomena known as 
horizontal gene transfer [13-14]. 
 
It is a recurrent and noticeable phenomenon that 
drug resistance of bacteria in community occurs 
following its emergency in clinical settings. The 
information on resistance pattern and plasmid 
profile of Staphylococcus species in community 
setting is limited. This study was therefore, 
carried out in order to evaluate the resistance 
pattern and plasmid profiles of Staphylococcus 
species isolated from clinical and community 
settings (defined as all isolates outside clinical 
setting). 
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2. MATERIALS AND METHODS 
 
2.1 Bacterial Isolates 
 
Staphylococcus species previously isolated from 
clinical and community settings and identified 
using Restriction Fragment Polymorphism 
supplemented with PCR species-specific primers 
were used for the study. The bacteria were 
isolated between 2007 and 2011 from various 
clinical and community based samples which 
were stored in 60% glycerol at -80°C. 
Preliminary microbiological tests as growth on 
mannitol salt agar, Gram staining, catalase, 
coagulase were used to rescreen these             
isolates. 
 
2.2 Sensitivity Test 
 
An overnight broth culture suspension of each 
isolate was serially diluted with sterile distilled 
water until the turbidity matched 0.5 McFarland 
standard. This was inoculated onto a Mueller 
Hinton agar prepared plates and the antibiotic 
discs were distributed maintaining a distance             
of 30 mm edge to edge. The tests were 
interpreted after 24 h of incubation at 37°C. The 
diameter of the inhibition zones was measured 
using ruler and interpreted according to the 
criteria recommended by the CLSI [15]. 
 
2.3 Plasmid Isolation and Electrophoresis 
 
Mini Prep method of Lech and Brent [16] was 
used as described below: Overnight broth culture 
of the organisms (1.5 ml) was transferred into 
eppendorff tubes and spanned for 1  minute at 
13, 000 rpm. The supernatant was decanted 
and then vortexed to re-suspend the cells. About 
300 µl of TENS solution (Tris 25 mM, EDTA 10 
Mm, NaOH 0.1 N and SDS 0.5%) was  added  
and  mixed by inversion for 3-5 minutes until 
the solution became sticky. A volume of 150 µl 
of 3.0 M sodium acetate (pH 5.2) was added 
and vortexed. This was followed by spinning for 
5minutes in a micro-centrifuge to pellet cell 
debris and chromosomal DNA. The supernatants 
were transferred to fresh eppendorff tubes and 
900 µl of ice-cold absolute ethanol was added. 
This was spanned for another 10minutes to 
pellet plasmid DNA. The supernatants were 
discarded while the pellet was washed twice 
with 1 ml of 70% ethanol and dried. The pellet 
was re-suspended in 40 µl of distilled water. The 
extracted plasmid (10 µl) was resolved by 0.8% 
agarose gel electrophoresis. 
3. RESULTS 
 
3.1 Sources of Isolates 
 
A total of 55 clinical Staphylococcus species 
were obtained of which Staphylococcus 
epidermidis from wound swabs accounted for 
36.4%, eye swab (20.0%), semen (14.5%), and 
ear swab (10.9%). Sputum, throat, soft tissue 
and high vagina swabs each had one                       
S. epidermidis (1.8%). Only urethral swab had   
S. xylosus (1.8%). In wound swabs, S. aureus 
(5.5%) were isolated while one S. aureus each 
was recovered from eye and ear specimens 
(Table 1). In community isolates (Table 2),                
S. epidermidis constituted the largest percentage 
(96.2%), with 71.70% recovered from human 
nostril, 17.0% in waste water, 1.9% in air, 1.9% 
on skin and 3.8% in private suite surfaces. One 
Staphylococcus aureus was isolated in both 
nostril and private suite surfaces. 
 
Table 1. Distribution of clinical isolates 
according to their sources 
 
Sources S. epidermidis S. xylosus S. aureus 
HVS 1 0 0 
Semen 8 0 0 
Ear 6 0 1 
Eye 11 0 1 
Soft tissue1 0 0 
Sputum 1 0 0 
Throat 1 0 0 
Urethra 0 1 0 
Wound 20 0 3 
Total 49 1 5 
 
Table 2. Distributions of community isolates 
according to their sources 
 
Sources S. epidermidis S. xylosus S. aureus 
Air 1 0 0 
Water 9 0 0 
Nostril 38 0 1 
Skin 1 0 0 
Private 
suite 
surface 
2 0 1 
Total 51 0 2 
 
3.2 Antibiograms 
 
In the clinical isolates of S. epidermidis, 30.9, 
34.5, 40.0, 41.8, 60.0, 76.4, and 89.1%                
were resistant to Chloramphenicol (CHL), 
Streptomycin (STR), Erythromycin (ERY), 
Gentamycin (GEN), and Tetracycline (TET) 
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Cotrimoxazole (COT), and Cloxacillin (CXC) 
respectively. Correspondingly, in community 
isolates of S. epidermidis, 28.3, 32.1, 50.9, 26.4, 
58.5, 90.6 and 92.5% were resistant to these 
antibiotics. In the clinical isolates of S. aureus, 
5.5, 5.5, 7.3, 7.3, 7.3, 9.1 and 9.1% were 
resistant to ERY, CHL, STR, GEN, TET, COT 
and CXC respectively. In community isolates, 
1.9% S. aureus were resistant to COT, CHL, 
ERY, GEN and STR while 3.8% were resistant 
to CXC. The only clinical S. xylosus, was 
resistant to all the antibiotics except CHL and 
STR (Table 3). Multiple resistance was also 
observed amongst the clinical and community 
isolates. In clinical isolates, 3 organisms were 
resistant to eight and seven different antibiotic 
classes while in community isolates, only two 
isolates were resistant to seven.  Also, 13 and 8 
clinical isolates were resistant to six and five 
antibiotic classes while 2 and 14 of community 
isolates were resistant the same number of 
antibiotics respectively. In the same way, 4 and 
12 clinical and 10 and 18 community isolates 
were resistant to four and three different 
antibiotic classes respectively (Figs. 1 and 2). 
 
3.3 Plasmid Profile and Analysis  
 
Plasmid profiles of selected clinical (35) and 
community (19) isolates with multiple drug 
resistance showed that 94.3% of clinical and 
89.5% of community isolates had plasmids of 
size 23.13kb (Fig. 3). 
 
4. DISCUSSION 
 
The evaluation of resistance pattern in this 
study reveals that high proportion of the isolates 
were resistant to most of the antibiotics in 
study. This was similar to few studies which 
reported increasing resistance of staphylococci 
to commonly used antibiotics [17-18]. This 
observation may not be surprising due to 
frequent abuse of most of these antibiotics 
especially those available from across the 
counter where they are sold with or without 
prescription in Nigeria [19]. Historically, 
resistance of clinical isolates of bacteria to 
antibiotics always outweigh that of community 
counterpart as a result of increasing antibiotic 
pressure. However, this study has shown that 
there are no significant difference in the 
resistance pattern between the clinical and 
community isolates to antibiotics tested except 
erythromycin and streptomycin. This is complete 
deviation from the earlier believe that community 
isolates have less tendency to develop 
resistance [20-22]. The implication of this is that 
community-acquired staphylococcal infection 
may be difficult to treat as the clinical 
 
 
 
Fig. 1. Multiple resistance pattern among clinical isolates 
Key: COT= Cotrimoxazole, STR =Streptomycin, CXC =Cloxacillin, TET =Tetracycline, ERY 
=Erythromycin, VAN =Vancomycin, GEN =Gentamicin, CHL= Chloramphenicol 
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Fig. 2. Multiple resistance pattern among community isolates 
Keys: COT= Cotrimoxazole, STR =Streptomycin, CXC =Cloxacillin, TET =Tetracycline, ERY 
=Erythromycin, VAN =Vancomycin, GEN =Gentamicin, CHL= Chloramphenicol 
 
counterpart. Therefore, only a handful of 
antibiotics may be available for treatment of 
community associated infections. It is therefore, 
likely that there was drift of resistance genes 
from bacteria within the clinical settings to 
bacterial isolates in the community which 
become an important reservoirs in the spread of 
antibiotic resistance especially where 
indiscriminate use of antimicrobial agents and 
antibiotics are prevalent. 
 
 
 
Fig. 3. Plasmid profiles of isolates of clinical and community isolates 
Lane M=Molecular marker (Hind111 lambda DNA), 1=isolate without plasmid, 2-12= isolates with plasmids 
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Table 3. Comparison of percentage resistance of clinical and community isolates to various antibiotics 
 
Antibiotics Clinical (n=55) Community (n=53) P 
S. epidermidis % S. aureus % S. xylosus % S. epidermidis % S. aureus % 
COT 42 76.4 5 9.1 1 1.8 48 90.6 1 1.9 0.457 
CHL 17 30.9 3 5.5 0 0 15 28.3 1 1.9 0.411 
CXC 49 89.1 5 9.1 1 1.8 49 92.5 2 3.8 - 
ERY 22 40.0 3 5.5 1 1.8 27 50.9 1 1.9 0.025a 
GEN 23 41.8 4 7.3 1 1.8 14 26.4 1 1.9 0.487 
STR 19 34.5 4 7.3 0 0 17 32.1 1 1.9 0.019a 
AUG 47 85.5 5 9.1 1 1.8 50 94.3 2 3.8 0.842 
TET 33 60.0 4 7.3 1 1.8 31 58.5 0 0 0.296 
Keys: P= level of significance (≤ 0.05), n= sample size, a= significant at 0.05 
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The multiple antibiotics resistance of coagulase 
negative staphylococci (CNS) observed in this 
study was similar to previous work [23] in which 
multiple resistance among the CNS reported to 
be as high as 80.77%. The antibiogram pattern 
in this study showed that S. epidermidis tends to 
be resistant to a wider range of antibiotics and 
this is consistent with a report in Lagos, Nigeria 
in which 77.0% of S. epidermidis were resistant 
[23]. The earlier review by Pfaller and Henweldt 
[24] indicates that S. epidermidis has become 
resistant to commonly used antibiotics which 
may serve as reservoir for antibiotic resistance 
strains in hospitals. These antibiotic resistant 
determinants can be transferred to new bacterial 
species as part of the large conjugative 
replicons which commonly code resistance to 
some aminoglycosides such as gentamycin, 
kanamycin [25]. The rising resistance profile of 
S. xylosus in this study was similar to a study of 
staphylococci associated with food and used in 
starter cultures in which these species (95%) 
were resistance to seven antibiotics [26]. The 
limited number of S. xylosus isolated hampered 
the overall scientific significance with respect to 
resistance. However, the resistance profile of    
S. xylosus has been previously documented [27]. 
The reason for the multiple antibiotic resistance 
in CNS is unknown, but transfer of genetic 
elements between CNS and S. aureus is a 
plausible cause. Also, CNS carries a variety of 
multiple resistance genes on their plasmid which 
can be exchanged and spread amongst different 
species of staphylococci including S. aureus. 
 
The plasmid analysis showed that 23.13 kb 
plasmid was similar to 23.13 kb identified 
previously [28] which harbor resistance 
determinant to β-lactam antibiotics. In this study, 
the homogeneity of the isolates with respect to  
antibiograms and plasmid profiles is an evidence 
of genetic transfer from a common source and 
this is likely to have arisen through horizontal 
gene transfer from a single strain or its 
derivatives from hospital to hospital and hospital 
to community and verse versa. Evolutionary 
events through recombination or transposition 
might have resulted to emergence of these 
strains. The frequent use of antibiotics has led to 
selective pressure to emergence of resistance 
determinants within many staphylococci as 
evidenced by outbreak of resistance mostly 
encountered following its introduction into clinical 
practice. Geetha and others [23] reported the 
successful transfer of R-plasmid in vivo by mixed 
culture transfer on solid media. This signifies 
the epidemiological significance of normal 
staphylococcal habitat in the emergence of 
antibiotic resistance with topical use of antibiotics 
which predispose the organisms to antibiotic 
selective pressure for plasmid gene expression. 
 
5.  CONCLUSIONS AND RECOMMENDA-
TION 
 
The increasing resistance and similarity of 
plasmid profile of the community isolates to 
clinical isolates call for urgent establishment of 
antibiotic surveillance system to minimize the 
emergence of drug resistance pathogens in         
the community. In addition, staphylococcal 
infections have been associated with significant 
morbidity and mortality in health-care institutions, 
therefore, accurate analysis of resistance and 
plasmid profiles may allow for provision of better 
antimicrobial therapy and epidemiological 
surveillance. Besides, the similarity in resistance 
and plasmid patterns of clinical and community 
isolates of staphylococcus species implies that 
community associated infections should be 
treated as a matter of urgency as the clinical 
counterpart. There is need for proper clinical 
documentation of drift in resistance pattern of 
staphylococci especially with emergence of 
MRSA in this region. Setting up antibiotic 
surveillance system could reduce the spread of 
staphylococcal resistance in the community 
setting. 
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